A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

distinguished for integrating advanced technology into its CGM products. The Medtronic Guardian Connect system not only monitors glucose levels but also utilizes predictive algorithms to forewarn ...

Medtronic is hoping that their efforts in the AID and "smart dosing" markets will pay off after largely missing out on the CGM market. They may be onto something. The recent ADA guidelines do ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best dividend stocks to buy and hold. In recent years, many investors have shifted their focus ...

Since the start of 2025, Medtronic plc (NYSE:MDT) has surged by nearly 10%. Earlier this year, the company secured US approval for its Simplera continuous glucose monitoring (CGM) system.

The MiniMed 780G with the Guardian 4 sensor. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) issued an urgent field safety ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been underperforming ...

The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best dividend stocks to buy ...